Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 29.47 -0.05 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.52 | 52 Week High | $5.17 | |||
| Open | $30.24 | 52 Week Low | $0.94 | |||
| Day High | $30.54 | P/E | N/A | |||
| Day Low | $29.38 | EPS | $0.00 | |||
| Volume | 1,089,527 | |||||
